Home » EUROSCREEN RECEIVES KEY PATENT FOR PURINERGIC RECEPTOR
EUROSCREEN RECEIVES KEY PATENT FOR PURINERGIC RECEPTOR
Euroscreen SA May 26 announced that it was awarded a US patent that covers the use of a G-protein-coupled receptor (GPCR) known as the human P2Y11 receptor. Euroscreen's patent protects the sequence of P2Y11 receptor and research tools comprising this sequence.
PR Web (http://www.prweb.com/releases/2006/5/prweb384934.htm)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May